⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
CORRECTING and REPLACING Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX
businesswire.com
DVAX
SNY
Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX
businesswire.com
DVAX
SNY
Honoring 45 Organ, Eye and Tissue Donors, Living Donors and Recipients: The 2026 OneLegacy Donate Life Rose Parade® Float Celebrates 23 Years of Participation in the Iconic Rose Parade®
businesswire.com
SNY
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
globenewswire.com
SNY
DVAX
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
globenewswire.com
SNY
Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia
globenewswire.com
SNY
Local Organ, Eye and Tissue Donors, Transplant Recipients and Living Donors to be Honored on the 2026 OneLegacy Donate Life Rose Parade® Float on New Year’s Day
businesswire.com
SNY
Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
globenewswire.com
REGN
SNY
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
globenewswire.com
REGN
SNY
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
globenewswire.com
SNY